Prokidney (PROK) Interest Coverage Ratio (2021 - 2026)
Prokidney's (PROK) quarterly Interest Coverage Ratio came in at 3.41 in Q1 2026, down 9.32% year-on-year from 3.77 in Q1 2025, and down 223.03% on a QoQ basis from 1.06 in Q4 2025.
Prokidney (PROK) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Interest Coverage Ratio data on file, last reported at 3.41 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 9.32% year-over-year to 3.41 in Q1 2026; TTM through Mar 2026 was 2.08, a 66.66% increase from a year earlier, with the FY2025 full-year figure at 3.84, up 58.79% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.41, down from 1.06 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PROK reached as high as 0.01 in Q1 2023 and fell as low as 25785.5 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 2367.59 across 5 years, with a median of 9.92 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 100.0% in 2023 and fell as far as 660660.44% in 2023.
- Year by year, Interest Coverage Ratio stood at 1.22 in 2022, then plunged by 660660.44% to 8070.0 in 2023, then sank by 219.52% to 25785.5 in 2024, then surged by 100.0% to 1.06 in 2025, then plunged by 223.03% to 3.41 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 3.41 in Q1 2026, 1.06 in Q4 2025, and 24.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -3.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.41 |
| Dec 31, 2025 | -1.06 |
| Sep 30, 2025 | -24.36 |
| Jun 30, 2025 | -3.42 |
| Mar 31, 2025 | -3.12 |
| Dec 31, 2024 | -25,785.50 |
| Sep 30, 2024 | -22.29 |
| Jun 30, 2024 | -3.49 |
| Mar 31, 2024 | -9.92 |
| Dec 31, 2023 | -8,070.00 |
| Sep 30, 2023 | -223.05 |
| Jun 30, 2023 | -2.34 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -1.22 |
| Sep 30, 2022 | -1,226.62 |
| Jun 30, 2022 | -121.99 |
| Mar 31, 2022 | -4,747.29 |
| Dec 31, 2021 | -13.80 |
| Sep 30, 2021 | -17,081.00 |